Abstract
Bestron was administered to pediatric patients with otitis media and its efficacy, safety and utility were evaluated. Results were as follows.(1) The improvement rate in 11 childrenwith infantile otitis media (9 cases of acute suppurative otitis media, 2 cases of chronic suppurative otitis media) was 90.9% (markedly improved in 4 cases, improved in 6 cases). The clinical response was excellent.(2) The improvement rate in 9 children with other types of otitis media (2 cases of exudative otitis media, 7 cases of postoperative relapse of chronic otitis media) was 88.9% (markedly improved in 4 cases, improved in 4 cases). Thus, the response was again excellent.(3) Audiometry in 9 children with infantile otitis media disclosed no drug-related abnormal changes.(4) No side effects were found. The above results indicate that Bestron for otic use in therapeutically very effective against infantile and other types of otitis media and has a high degree of safety, thus promising a high clinical utility.
